{{header
 | author     = 
 | related_author = United States Congress
 | translator = 
 | section    = 
 | previous   = 
 | next       = 
 | year       = 2013
 | month      = 01
 | day        = 23
 | notes      = ''{{USBill|113||77}}'' as introduced
 | categories =
 | portal     =
 | congress   = 113
 | session    = 1
 | title      = Prescription Drug and Health Improvement Act of 2013 ( S. 77; 113th Congress)
 | bill       = 77
 | billtype   = s
 | purpose    = To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs.
 | wikipedia  =
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|S. 77}}


{{Center|IN THE SENATE OF THE UNITED STATES}}


{{Center|January 23 (legislative day, January 3), 2013}}


{{Center|
[[w:|Mr. Franken]] (for himself and
[[w:|Ms. Klobuchar]] ) introduced the following bill; which was read twice and referred to the [[w:United States Senate Committee on Finance|Committee on Finance]] }}


{{Center|A BILL}}

To amend part D of title XVIII of the Social Security Act to authorize the Secretary of Health and Human Services to negotiate for lower prices for Medicare prescription drugs.

=Section 1. Short title=

This Act may be cited as the “Prescription Drug and Health Improvement Act of 2013” .

=Sec. 2. Negotiating fair prices for medicare prescription drugs=



==(a) Negotiating fair prices– ==



===(1) In general– ===

 Section 1860D–11 of theSocial Security Act( [http://www.law.cornell.edu/uscode/text/42/1395w–111 42 U.S.C. 1395w–111] )is amended by striking subsection (i)(relating to noninterference) and by inserting the following:

<blockquote>

====(i) Authority To negotiate prices with manufacturers– ====

In order to ensure that beneficiaries enrolled under prescription drug plans and MA–PD plans pay the lowest possible price, the [[w:Department of Health and Human Services|Secretary]] shall have authority similar to that of other Federal entities that purchase prescription drugs in bulk to negotiate contracts with manufacturers of covered part D drugs, consistent with the requirements and in furtherance of the goals of providing quality care and containing costs under this part..
</blockquote>


===(2) Effective date– ===

The amendment made by paragraph (1)shall take effect on the date of the enactment of this Act.

==(b) Biannual reports to Congress– ==

Not later than 1 year after the date of the enactment of this Act, and every 6 months thereafter, the [[w:Department of Health and Human Services|Secretary of Health and Human Services]] shall submit to [[w:United States Congress|Congress]] a report on the negotiations conducted by the [[w:Department of Health and Human Services|Secretary]] under section 1860D–11(i) of the Social Security Act( [http://www.law.cornell.edu/uscode/text/42/1395w–111 42 U.S.C. 1395w–111(i)] ), as amended by subsection (a), including a description of how such negotiations are achieving lower prices for covered part D drugs (as defined in section 1860D–2(e) of theSocial Security Act( [http://www.law.cornell.edu/uscode/text/42/1395w–102 42 U.S.C. 1395w–102(e)] )) for Medicare beneficiaries.
{{PD-USGov}}
[[Category:Proposed United States federal law]]
[[Category:Proposed United States federal law of the 113th Congress]]
